Drug Watch: E-Therapeutics raises £40m

Drug Watch: E-Therapeutics raises £40m

E-therapeutics (ETX) secured its funding needs for the next four years after the biotech secured a notable £40m fundraising. The proceeds from the raising will boost the company's cash resources to £48m, more than its current market capitalisation. E-Therapeutics' ability to raise money, particularly with heavyweight backing from Invesco, was noted two years ago when it first raised £17m in a tight market. But the difference this time is that e-Therapeutics is taking a much clearer view about what sort of products it wants to develop.

To continue reading, register today

to enjoy limited access to the following:

  • Daily trading news
  • Funds coverage
  • Features on big investment themes
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now